Not Yet RecruitingPhase 2

Direct Comparison of Ga-68-DOTATATE and Ga-68-DOTATOC

United States6 participantsStarted 2026-06

Plain-language summary

The goal of this study is to propose the first direct comparison of Ga-68-DOTATATE PET/CT or PET/MR and Ga-68-DOTATOC PET/CT in patients with meningioma.

Who can participate

Age range18 Years – 89 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Adult patients with clinically suspected meningioma * Patients planned for surgery - undergoing preoperative workup * No contraindications to either radiotracer Exclusion Criteria: * Age less than 18 years * Inability to lay on the scanner table for the required period of time, e.g., due to bone pain or claustrophobia.

What they're measuring

Qualitatively measure the visual appearance of target lesion to cranial blood pool using the maximum SUV ratio to compare results from Ga-68-DOTATATE and -DOTATOC PET.

Timeframe: Over 12 months

Quantitatively measure the visual appearance of target lesion to cranial blood pool using the maximum SUV ratio to compare results from Ga-68-DOTATATE and -DOTATOC PET.

Timeframe: Over 12 months

Trial details

NCT IDNCT04298541

SponsorWeill Medical College of Cornell University

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2026-06

Contact for this trial

Jana Ivanidze, MD/Ph.D

212-746-6000 jai9018@med.cornell.edu

View on ClinicalTrials.gov More Meningioma trials